Join us in celebrating our 50th Anniversary!
Join us in celebrating our 50th Anniversary!

Read Great Content from CLSI

Company Develops Accurate Dengue Outbreak Prediction Platform

Artificial Intelligence in Medical Epidemics (AIME), a startup company, has developed a new software that can accurately predict the spread of Dengue three months ahead of an outbreak. AIME claims that the platform, Dengue Outbreak Prediction, now has an average accuracy of 86.4 percent.

Read More

Potential New Weapon in the Fight Against Antimicrobial Resistance

A forgotten antibiotic has shown promise in treating antimicrobial resistant bacteria. Octapeptin, an antimicrobial drug discovered several decades ago, may be the next weapon in the war against antimicrobial resistant superbugs. Matt Cooper, director of the University of Queensland Institute for Molecular Bioscience’s Centre for Superbug Solutions, said “Octapeptins were discovered in the late 1970s but were not selected for development at the time, as there was an abundance of new antibiotics with thousands of people working in antibiotic research and development.”

Read More

CLSI Partners with Dominican Republic to Provide HIV Testing Training

CLSI has been providing training in the Dominican Republic since 2016 for 11 HIV point-of-care-testing (POCT) sites as well as the National Reference Laboratory (National Public Health Laboratory Dr. Defilio). The scope of CLSI’s work in the Dominican Republic is focused on supporting the UNAIDS Initiative 90-90-90 program...

Read More

How CLSI Got the QSEs

By Lucia M. Berte, MA, MT(ASCP)SBB, DLM, CQA(ASQ)CMQ/OE, Laboratories Made Better! The “Quality System Essentials (QSEs)” have been part of CLSI’s lexicon since it was still NCCLS—and now for almost 20 years—but the phrase was not invented by this organization’s volunteers. In the mid-1990s, when the U.S. Food and Drug Administration started citing blood banks and transfusion services for violating the good manufacturing practice (GMP) regulation, the American Association of Blood Banks (AABB) began integrating these requirements into their Standards publications and accreditation assessments...

Read More

CLSI Furthers Its Mission

Last month the US Food & Drug Administration launched a new website that will make it easier for prescribers to give their patients the most accurate antimicrobial treatment. They’ll base this information, in part, on the data provided in several of CLSI’s antimicrobial susceptibility testing (AST) standards. This new and improved way of providing breakpoint information to laboratories will help CLSI further its mission to develop clinical and laboratory practices and promote their use worldwide.

Read More